Clinical Trial Update: Prediction of Response to Treatment With Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer

View source ↗

Summary

A completed clinical trial update investigating predictive factors for response to a regimen of immunotherapy plus chemotherapy in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Lille | Conditions: Non-small Cell Lung Cancer | Status: COMPLETED